Consultations
We consult on proposed changes to the way we regulate medicines, medical devices and biologicals. Additional consultations about changes to the Poisons Standard can be found in the Scheduling decisions (interim) section of our publications hub.
See all open and recent consultations, submissions and decisions at the TGA Consultation hub.
More on consultations
Find more scheduling consultations on the Poisons Standard in our Interim decisions.
Trove at the National Library of Australia has information on archived TGA consultations and reviews.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Scheduling (national classification system) (74)
- Therapeutic goods regulation (18)
- Over the counter (OTC) medicines (14)
- Prescription medicines (14)
- Legislation (11)
- Complementary medicines (9)
- Non-prescription medicines (9)
- Advisory bodies and committees (8)
- Listed medicines (8)
- Labelling and packaging (6)
- Manufacturing (6)
- Medical devices safety (4)
- Advertising (3)
- In Vitro Diagnostic medical devices (IVDs) (3)
- Medicines safety (3)
- Sunscreens (3)
- Australian Register of Therapeutic Goods (ARTG) (2)
- Fees and payments (2)
- Import and export (2)
- Safety (2)
- Shortages (2)
- Artificial Intelligence (AI) (1)
- Clinical trials (1)
- Disinfectants/Sterilants (1)
- Medicinal cannabis hub (1)
- Unique Device Identification (UDI) hub (1)
- Vaping hub (1)
Please use the filters or search function to help find relevant consultations.
Results for
"[search-keyword]"
Search
243 result(s) found, displaying 26 to 50
-
ConsultationHave your say on proposed amendments to the Poisons Standard, to be considered at advisory committees in November 2023.
-
ConsultationWe conducted a public consultation to seek feedback from interested parties on proposed changes to the requirements of ingredients used in listed (low-risk) medicines.
-
ConsultationWe are seeking feedback on the proposed new ‘Guidelines for the Quality of Listed Probiotic Medicines’.
-
ConsultationThe TGA is sought feedback on how we select medical device applications for audit and how we conduct these audits.
-
ConsultationThe TGA periodically reviews requirements for medical devices to ensure they continue to be appropriate. Closing 28 July 2023.
-
ConsultationThe TGA is seeking feedback on proposed clarification and updates to the regulation of sunscreens. Closing date: 31 May 2023
-
ConsultationProposed amendments to the Poisons Standard. Closing date: 17 May 2023
-
ConsultationThe TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on regulatory pathways for medical devices manufactured at the point-of-care. Closing date: 7 May 2023
-
ConsultationThe TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on regulatory pathways for medical devices manufactured at the point-of-care. Closing date: 7 May 2023
-
ConsultationThe TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on regulatory pathways for medical devices manufactured at the point-of-care. Closing date: 7 May 2023
-
ConsultationThe TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on regulatory pathways for medical devices manufactured at the point-of-care. Closing date: 7 May 2023
-
ConsultationThe TGA is conducting a public consultation to provide interested stakeholders with an opportunity to comment on options for the TGA's proposed fees and charges for the 2023-24 financial year. Closing date: 20 March 2023
-
ConsultationThe TGA is seeking feedback on improvements to the therapeutic goods recalls process. Closing 13 March 2023.
-
ConsultationThis consultation is for the interim decision in relation to paracetamol which was discussed at the November 2022 meeting of the Advisory Committee on Medicines Scheduling (ACMS).
-
ConsultationThis consultation is for interim decisions made in relation to the other substances that were discussed at the November 2022 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationProposed amendments to the Poisons Standard. Closing date: 3 February 2023
-
ConsultationThe TGA is seeking public comment on potential reforms to the regulation of nicotine vaping products (NVPs) in Australia.
-
ConsultationThe TGA is seeking views on ingredient names that must be displayed as both the old and new ingredient name on medicine labels.
-
ConsultationThis consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the Poisons Standard, following advice sought at the June 2022 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationThis consultation is for interim decisions made in relation to Psilocybine and MDMA proposals to amend the Poisons Standard, following advice sought at the June 2022 meetings of the Advisory Committee on Medicines Scheduling (ACMS).
-
ConsultationWe sought feedback on the draft guidance ‘Boundary and combination products - medicines, medical devices, and biologicals’. Read about the outcome of this consultation.
-
ConsultationThe TGA is seeking feedback on whether certain international scientific guidelines should be adopted.
-
ConsultationThe TGA is considering regulatory options to allow advertisers, including product sponsors, to make references to the TGA in advertising (including on product labels).
-
ConsultationClosing date: 14 October 2022
-
ConsultationThe TGA is seeking feedback on the third consultation paper published by the TGA relating to the Australian implementation of a Unique Device Identification (UDI) System for medical devices.